Bimekizumab is safe and effective and shows sustained clinical benefits in patients with moderate-to-severe hidradenitis suppurativa, a real-world study spanning 48 weeks shows.
Medscape News UK
Source link : https://www.medscape.com/viewarticle/bimekizumab-maintains-long-term-effectiveness-and-safety-2025a1000n2y?src=rss
Author :
Publish date : 2025-09-04 12:00:00
Copyright for syndicated content belongs to the linked Source.
